Literature DB >> 17883592

Protease-activated receptor-induced Akt activation--regulation and possible function.

J C Reséndiz1, M H Kroll, R Lassila.   

Abstract

BACKGROUND: Thrombin induces the activation of the platelet serine/threonine kinase Akt. Akt activation is dependent on its phosphorylation at Thr308 and Ser473. The mechanism by which thrombin induces Akt phosphorylation is controversial, as is the role of Akt in platelet function.
OBJECTIVES: To investigate how protease-activated receptors (PARs) stimulate Akt and the role that Akt plays in human platelet function.
METHODS: Platelets were stimulated through PAR1 or PAR4. Specific inhibitors were used to evaluate, by Western blotting, signaling pathways regulating Akt phosphorylation, and the role of activated Akt was evaluated by aggregometry and flow cytometry.
RESULTS: Phospholipase C (PLC) controls Akt phosphorylation elicited by PARs. Stimulation of PAR1 or PAR4 resulted in rapid Akt phosphorylation, independently of secreted ADP and phosphatidylinositol-3-kinase (PI3K) activation. Akt phosphorylation approximately 60 s after PAR1 stimulation became entirely dependent on the purinergic receptor P2Y(12) and the activation of PI3K. In contrast, PAR4 partially sustained Akt phosphorylation independently of P2Y(12) and PI3K for up to 300 s. Pharmacologic inhibition of Akt reduced P-selectin expression and fibrinogen binding in platelets stimulated through PAR1, and delayed platelet aggregation in response to submaximal PAR1 or PAR4 stimulation, although aggregation at 300 s was unaffected.
CONCLUSIONS: Platelet PAR stimulation causes rapid Akt phosphorylation downstream of PLC, whereas with continuous stimulation, ADP and PI3K are required for maintaining Akt phosphorylation. Activated Akt regulates platelet function by modulating secretion and alpha(IIb)beta(3) activation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17883592     DOI: 10.1111/j.1538-7836.2007.02769.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  16 in total

1.  A G(i) -independent mechanism mediating Akt phosphorylation in platelets.

Authors:  B Xiang; G Zhang; J Liu; A J Morris; S S Smyth; T K Gartner; Z Li
Journal:  J Thromb Haemost       Date:  2010-09       Impact factor: 5.824

2.  Arrestin-2 differentially regulates PAR4 and ADP receptor signaling in platelets.

Authors:  Dongjun Li; Lauren D'Angelo; Massiel Chavez; Donna S Woulfe
Journal:  J Biol Chem       Date:  2010-11-24       Impact factor: 5.157

3.  Akt signaling in platelets and thrombosis.

Authors:  Donna S Woulfe
Journal:  Expert Rev Hematol       Date:  2010-02       Impact factor: 2.929

4.  Whole blood gene expression analyses in patients with single versus recurrent venous thromboembolism.

Authors:  Deborah A Lewis; Gregg J Stashenko; Olga M Akay; Lulit I Price; Kouros Owzar; Geoffrey S Ginsburg; Jen-Tsan Chi; Thomas L Ortel
Journal:  Thromb Res       Date:  2011-07-07       Impact factor: 3.944

5.  Thrombin induces NF-kappaB activation and IL-8/CXCL8 expression in lung epithelial cells by a Rac1-dependent PI3K/Akt pathway.

Authors:  Chien-Huang Lin; Hui-Wen Cheng; Hon-Ping Ma; Chih-Hsiung Wu; Chuang-Ye Hong; Bing-Chang Chen
Journal:  J Biol Chem       Date:  2011-01-25       Impact factor: 5.157

6.  The roles and mechanisms of PAR4 and P2Y12/phosphatidylinositol 3-kinase pathway in maintaining thrombin-induced platelet aggregation.

Authors:  Chin-Chung Wu; Shih-Yun Wu; Chieh-Yu Liao; Che-Ming Teng; Yang-Chang Wu; Sheng-Chu Kuo
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

Review 7.  Platelet-neutrophil interactions under thromboinflammatory conditions.

Authors:  Jing Li; Kyungho Kim; Andrew Barazia; Alan Tseng; Jaehyung Cho
Journal:  Cell Mol Life Sci       Date:  2015-02-04       Impact factor: 9.261

8.  Protease-activated receptors in cancer: A systematic review.

Authors:  Na Han; Ketao Jin; Kuifeng He; Jiang Cao; Lisong Teng
Journal:  Oncol Lett       Date:  2011-04-08       Impact factor: 2.967

9.  Blockade of PAR1 signaling with cell-penetrating pepducins inhibits Akt survival pathways in breast cancer cells and suppresses tumor survival and metastasis.

Authors:  Eric Yang; Adrienne Boire; Anika Agarwal; Nga Nguyen; Katie O'Callaghan; Powen Tu; Athan Kuliopulos; Lidija Covic
Journal:  Cancer Res       Date:  2009-07-21       Impact factor: 12.701

10.  Protease-Activated Receptor 1 Enhances Poly I:C Induction of the Antiviral Response in Macrophages and Mice.

Authors:  Silvio Antoniak; Kohei Tatsumi; Michael Bode; Swetha Vanja; Julie C Williams; Nigel Mackman
Journal:  J Innate Immun       Date:  2016-11-08       Impact factor: 7.349

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.